Type 1 Diabetes & Clinical Islet Transplant Friendocrinologist, Director, Alberta Diabetes Institute Charles A. Allard Chair in Diabetes Research
Edmonton, Alberta
Joined May 2009
- Tweets2.9K
- Following268
- Followers2.3K
- Likes1.3K
Dr Peter A Senior retweeted
Join the diabetes research community on June 5 at the @AlbertaDiabetes and @GairdnerAwards Scientific Symposium as part of the 25th anniversary celebrations of the Edmonton Protocol.
This exciting event will include sessions on beta cell replacement therapy, immune responses and islet cell biology, along with a panel discussion on future research priorities.
If you’re a researcher, clinician or trainee interested in diabetes research, we’d love to see you there.
Happening 8:30 a.m. - 4:30 p.m. at the University of Alberta’s Telus International Centre.
Reserve your spot: uab.ca/protocol25
Dr Peter A Senior retweeted
“You are a speck in your patient’s life”. “Your half life of influence is measured in minutes” Sobering and real facts from Dr Michael Vallis #DUO25
Dr Peter A Senior retweeted
Register Now for C-Path's 21ˢᵗ Century Trials in New-Onset Type 1 Diabetes Virtual Workshop! How the Use of C-Peptide can Accelerate the Development of Next-Gen Disease-Modifying Therapies for T1D.
Register now: f.mtr.cool/kyusvpnkiv
#CPath20Years #T1D
Dr Peter A Senior retweeted
A huge loss for Canadian science and the global cardiometabolism community @UAlberta @CIHR_IRSC @HeartandStroke @DiabetesCanada
This Post is from a suspended account. Learn more
Dr Peter A Senior retweeted
Important diabetes news. Unfortunately, while VX264 (Vertex's encapsulated stem cell derived islet product) has been safe in patients, the company has discontinued the trial due to insufficient function of the cells. investors.vrtx.com/news-rele…
Dr Peter A Senior retweeted
Day 2 of the DC/CSEM Professional Conference in Halifax. We celebrated 25 years of the Edmonton Protocol: a method for treating type 1 diabetes by implanting pancreatic islets. Other key highlights included our 2024 Research Award Ceremony. Day 3 here we come!
Dr Peter A Senior retweeted
In #kidney #transplant recipients with type 1 #diabetes, IAK transplantation was associated with a significantly better patient-graft survival compared with kidney transplantation alone, mainly due to a protective effect on the risk of death thelancet.com/journals/landi… #T1D
Dr Peter A Senior retweeted
LOVE this #T1D @DiabetesCanada CPG chapter update - in DRAFT - but oh so good! #dccan24 @bwicklow1 Dr Ilana Halperin. Bravo!
Dr Peter A Senior retweeted
This CanScreen T1D Project will establish a Canadian clinical lab at Alberta Precision Laboratories to test for type 1 diabetes (T1D) autoantibodies. It will select a safe and quick screening method to detect T1D risk early, aid clinical trials, and clarify uncertain diagnoses.🔬
Dr Peter A Senior retweeted
Dr. James Shapiro receives the Canadian Association of General Surgeons Career Excellence in Research Award. “We’ve shown very clearly that islet transplantation is an effective therapy for patients with difficult-to-control Type 1 diabetes,” says Dr. Shapiro. #Surgicalresearch
Dr Peter A Senior retweeted
📈The percentage of Type 1 diabetes patients prescribed either GLP-1RAs or SGLT2 inhibitors increased from 0.7% to 8.3%.
💉GLP-1RAs
0.3% (2010) ➡️6.6% (2023)
💊📈SGLT2 inhibitors
0.1% (2010) ➡️2.4% (2023)
Dr Peter A Senior retweeted
With less than a month until we meet @AsilomarSB for the #WRISG2024 meeting we are thrilled to announce the recipients of the award lectures …🥁…. Congratulations to @bcellorg this years recipient of the Gerald M Grodksy Prize 🏆 👏👏👏👏👏👏👏👏👏👏👏👏👏👏👏
Dr Peter A Senior retweeted
The big reveal … @bcellorg delivers an amazing Grodsky Lecture #WRISG2024 - shout out to @KravetsVira for the patch-seq t-shirt @WRISGMeeting
Dr Peter A Senior retweeted
🌟 Meet CanScreen T1D 🌟
We’re a national consortium uniting the voices of the public, researchers, and healthcare providers to explore a screening program for type 1 diabetes in Canada. Our goal? Identify at-risk children and ensure our program meets community needs. Join us! 💙
Dr Peter A Senior retweeted
UPDATE: Health Canada has approved the first clinical trial of the oral drug tolimidone in humans with Type 1 diabetes.
Read via Folio: bit.ly/3TVC56S
Dr Peter A Senior retweeted
Please acknowledge things properly. If unsure how, ask. And if I decline a co-authorship, and ask instead for acknowledgement of our OPOs, then make some effort (especially if it involves samples, like T1D islets). It’s important for our program.
bcell.org/acknowledging-us.h…
Dr Peter A Senior retweeted
“Nearly 90% of people living with type 1 diabetes and nearly 70% of people living with type 2 diabetes experience shame and blame for having diabetes, according to this new survey.”
Important for people living with #diabetes, the general population, media, clinicians and policy makers
We need to #enddiabetesstigma
diabetes.ca/media-room/press…
Dr Peter A Senior retweeted
Exciting new chapter! 🚀 The CanScreen T1D consortium kicked off our inaugural conference on Sep 23, 2024. Huge thanks to our partners for their support! Together, we’re advancing type 1 diabetes research. 💪✨
@JDRF_Canada @CIHR_IRSC @_DiabetesAction – at Toronto, Ontario
Dr Peter A Senior retweeted
We are hiring in the CIHR CanScreenT1D consortium to initiate pilot screening for T1D in Canada.
We are looking for someone ontario-based who has expertise in patient engagement and integrating EDI principles into that work. Job advert below!
linkedin.com/jobs/view/40273….